From Pfizer to Moderna: who's making billions from Covid-19 vaccines?
by Julia Kollewe from on (#5F0JQ)
The companies in line for the biggest gains - and the shareholders who have already made fortunes
The arrival of Covid-19 vaccines promises a return to more normal life - and has created a global market worth tens of billions of dollars in annual sales for some pharmaceutical companies.
Among the biggest winners will be Moderna and Pfizer - two very different US pharma firms which are both charging more than $30 per person for the protection of their two-dose vaccines. While Moderna was founded just 11 years ago, has never made a profit and employed just 830 staff pre-pandemic, Pfizer traces its roots back to 1849, made a net profit of $9.6bn last year and employs nearly 80,000 staff.
Continue reading...